Clinical Application of a Brain Image Analysis Program for Multiple Sclerosis Part 1: MS and Diagnostic Imaging

In recent years, the pathogenesis of multiple sclerosis has become better understood, and new therapeutic agents have been developed one after another. In order to understand the pathogenesis of multiple sclerosis, it is important to measure brain volume and lesion volume.

Dr. Kenzo Sakurai, St. Marianna University School of Medicine, has written a three part series of articles on the significance of brain volume measurement using a brain image analysis program, titled “Clinical Application of a Brain Image Analysis Program for Multiple Sclerosis.”

We are pleased to share the first article from the series titled “Multiple Sclerosis and Diagnostic Imaging.” We hope that you will enjoy it.
(Feb 01, 2022)

URL

This field is for validation purposes and should be left unchanged.

Your NameRequired

Email AddressRequired

*If you have set up domain rejection, please check your email receiving settings to allow emails from [@micron-kobe.com].

Company / OrganizationRequired

Department / Faculty NameRequired

Position

Phone Number

Purpose

Inquiry Details

Micron Updates

I would like to receive updates from Micron.

Notes on Contact Form

ConfirmationRequired

I agree to the above notes and confirm that I have reviewed the contents of this form.

Please feel free to contact us

We provide comprehensive, end‑to‑end clinical development support, with imaging at its core.

With more than 20 years of experience, our team of imaging specialists in Japan and around the world tackles the complex challenges of imaging evaluation in pharmaceutical and medical device development. We deliver optimal, project‑specific solutions for each client.

Downloads